These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6549907)

  • 1. Clinical endpoints in trials of drugs for cancer: time for a rethink?
    Koopmans PP
    BMJ; 2002 Jun; 324(7350):1389-91. PubMed ID: 12052814
    [No Abstract]   [Full Text] [Related]  

  • 2. Joint adolescent-adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform-ACCELERATE.
    Gaspar N; Marshall LV; Binner D; Herold R; Rousseau R; Blanc P; Capdeville R; Carleer J; Copland C; Kerloeguen Y; Norga K; Pacaud L; Sevaux MA; Spadoni C; Sterba J; Ligas F; Taube T; Uttenreuther-Fischer M; Chioato S; O'Connell MA; Geoerger B; Blay JY; Soria JC; Kaye S; Wulff B; Brugières L; Vassal G; Pearson ADJ;
    Ann Oncol; 2018 Mar; 29(3):766-771. PubMed ID: 29351570
    [No Abstract]   [Full Text] [Related]  

  • 3. Reimagining the future of cancer clinical trials: Reformers are eyeing multiple ways to make drug trials more efficient, patient-centered, and likely to succeed.
    Nelson B; Faquin W
    Cancer Cytopathol; 2024 Jun; 132(6):331-332. PubMed ID: 38829676
    [No Abstract]   [Full Text] [Related]  

  • 4. Does Duration of Adverse Events Matter in Cancer Clinical Trials?
    Zhang S; Li W
    J Clin Oncol; 2024 Jul; 42(19):2358. PubMed ID: 38657188
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigating the Benefits of Collecting Low- and Moderate-Grade Adverse Events in Cancer Clinical Trials.
    Selukar S
    J Clin Oncol; 2024 Jul; 42(19):2358-2359. PubMed ID: 38657182
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical cancer research 2001: new agents and therapies.
    Verweij J; de Vries EG
    Drug Resist Updat; 2001 Aug; 4(4):217-23. PubMed ID: 11991676
    [No Abstract]   [Full Text] [Related]  

  • 7. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase 0 (zero) clinical trials: a myth or reality?
    Jain A
    Indian J Cancer; 2010; 47(1):70. PubMed ID: 20071795
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current status and issues in clinical trials of anticancer agents].
    Kojima H
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():295-301. PubMed ID: 7986107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical drug trials.
    Edgar L
    Can Nurse; 1983 Feb; 79(2):24-5. PubMed ID: 6549907
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent proposals for early stage clinical trials of cancer].
    Ohashi Y
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():292-4. PubMed ID: 7986106
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.